Siemens Healthineers Expands Brain Health Research Portfolio with New Blood-Based Tau Assays

Siemens Healthineers has announced the availability of two new blood-based biomarker assays for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays. The launch marks an expansion of the company’s brain health research portfolio, with the tests designed to help scientists better understand neurological function and disease … Read more

Diabetes Testing Moves Earlier—and Gets More Complex

By Alyx Arnett For decades, the clinical lab’s contribution to diabetes care followed a familiar script: A patient showed up with symptoms, a clinician ordered an A1C or fasting glucose test, and the lab returned a number confirming the diagnosis. That model is starting to shift. The 2026 American Diabetes Association Standards of Care place … Read more